5/27/2022 2:09:32 AM
GSK: China's NMPA Approves Cervarix For Girls Aged 9-14 Against Certain Types Of Cancer-causing Human Papillomavirus
4/27/2022 2:23:54 AM
GlaxoSmithKline Q1 Total EPS 35.9p And Adjusted EPS 32.8p
4/21/2022 7:59:15 AM
CureVac, GSK's Bivalent MRNA Vaccine Shown To Be Highly Effective Against SARS-CoV-2 Variants
4/19/2022 2:06:49 AM
GlaxoSmithKline Says FDA Accepts NDA For Daprodustat
4/13/2022 2:03:08 AM
GSK Agrees To Buy Sierra Oncology For $1.9 Bln
4/11/2022 8:52:40 AM
CureVac, GSK Reach Pandemic Preparedness Contract With German Government
4/1/2022 8:44:44 AM
GSK Publishes Segment And Product Sales Reporting Changes
3/30/2022 8:54:50 AM
CureVac, GSK Start Clinical Development Of Second-Generation COVID-19 Vaccine Candidate, CV2CoV
3/15/2022 6:03:45 AM
GlaxoSmithKline Appoints Six Directors To Designate Board Of Haleon
3/1/2022 2:18:38 AM
GSK: EMA Accepts Marketing Authorisation Application For Daprodustat For Patients With Anaemia Of Chronic Kidney Disease